Basic characterization of 64Cu-ATSM as a radiotherapy agent-Reference-Cited by-同舟云学术

Basic characterization of 64Cu-ATSM as a radiotherapy agent

Published:2005-01 Issue:1 Volume:32 Page:21-28
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Obata Atsushi,Kasamatsu Shingo,Lewis Jason S.,Furukawa Takako,Takamatsu Shinji,Toyohara Jun,Asai Tatsuya,Welch Michael J.,Adams Susan G.,Saji Hideo,Yonekura Yoshiharu,Fujibayashi Yasuhisa

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Molecular Medicine

Reference41 articles.

1. Trials and tribulations: oncological antibody imaging comes to the fore;Zuckier;Semin. Nucl. Med.,1997

2. Radioimmunotherapy for acute leukemia;Burke;Cancer Control,2002

3. Cell surface receptor-targeted therapy of acute myeloid leukemia: a review;Frankel;Cancer Biother. Radiopharm.,2000

4. Radioimmunotherapy of B-cell non-Hodgkin's lymphoma;Postema;Eur. J. Nucl. Med.,2001

5. Combined modality radioimmunotherapy. Promise and peril;Burke;Cancer,2002

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Radionuclide Therapy in Glioblastoma;ACS Applied Materials & Interfaces;2024-07-23

2. Occupational Radiation Exposure Associated with Radiotheranostics: Nuclear Medicine from Diagnosis to Therapy;RADIOISOTOPES;2024-07-15

3. HNODThia: A Promising Chelator for the Development of ⁶⁴Cu Radiopharmaceuticals;Inorganic Chemistry;2023-07-24

4. In vitro and in vivo characterization of [64Cu][Cu(elesclomol)] as a novel theranostic agent for hypoxic solid tumors;European Journal of Nuclear Medicine and Molecular Imaging;2023-06-29

5. Advances in PET and MRI imaging of tumor hypoxia;Frontiers in Medicine;2023-02-09